SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity. (2018)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-18-0937
PubMed Identifier: 30068710
Publication URI: http://europepmc.org/abstract/MED/30068710
Type: Journal Article/Review
Volume: 24
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 22
ISSN: 1078-0432